EASTGATE BIOTECH CORP
company.status.inactiveCIK 1099574fmd_1Z6FKVPM1QJSGTZQB78BHE0EMRFinance, Insurance and Real Estate · Investors, NECTemplate: Standard
Coverage: Jan 01, 2005 to Sep 30, 2017, 35 periods
Latest annual · FY2015
Millions- Gross profit
- 0
- Operating income
- (3)
- Net income
- (3)
Latest quarter · Q3 FY2017
Millions- Total revenues
- 0
- Gross profit
- (0)
- Operating income
- (2)
- Net income
- (2)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2011 to FY2016
- n/m
EASTGATE BIOTECH CORP financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2016 | FY2015 | Change | Source |
|---|---|---|---|---|
| Operating income | -$2.6 million | -$4.2 million | 10-K 2018-03-01 · proof | |
| Net income | -$3 million | -$4.3 million | 10-K 2018-03-01 · proof | |
| Cash from operating activities | -$389,478 | -$568,444 | 10-K 2018-03-01 · proof | |
| Total assets | $0 | $297,919 | -100% | 10-K 2018-03-01 · proof |
| Total liabilities | $4.6 million | $2.8 million | +66.2% | 10-K 2018-03-01 · proof |
| Cash and cash equivalents | $0 | $19,241 | -100% | 10-K 2018-03-01 · proof |
- What was EASTGATE BIOTECH CORP's operating income in fiscal 2016?
- EASTGATE BIOTECH CORP reported operating income of -$2.6 million for fiscal 2016 (the year ended Dec 31, 2016), against -$4.2 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2018. SEC
- What was EASTGATE BIOTECH CORP's net income in fiscal 2016?
- EASTGATE BIOTECH CORP reported net income of -$3 million for fiscal 2016 (the year ended Dec 31, 2016), against -$4.3 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2018. SEC
- What was EASTGATE BIOTECH CORP's cash from operating activities in fiscal 2016?
- EASTGATE BIOTECH CORP reported cash from operating activities of -$389,478 for fiscal 2016 (the year ended Dec 31, 2016), against -$568,444 the year before. Source: the 10-K filed with the SEC on Mar 1, 2018. SEC
- What are EASTGATE BIOTECH CORP's total assets?
- As of Dec 31, 2016, EASTGATE BIOTECH CORP reported total assets of $0, against $297,919 a year earlier (-100%). Source: the 10-K filed with the SEC on Mar 1, 2018. SEC
- What are EASTGATE BIOTECH CORP's total liabilities?
- As of Dec 31, 2016, EASTGATE BIOTECH CORP reported total liabilities of $4.6 million, against $2.8 million a year earlier (+66.2%). Source: the 10-K filed with the SEC on Mar 1, 2018. SEC
- What are EASTGATE BIOTECH CORP's cash and cash equivalents?
- As of Dec 31, 2016, EASTGATE BIOTECH CORP reported cash and cash equivalents of $0, against $19,241 a year earlier (-100%). Source: the 10-K filed with the SEC on Mar 1, 2018. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1099574&period_type=annual&limit=5"Information only, not investment advice.